Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.19.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of March 31, 2019, December 31, 2018, March 31, 2018 and December 31, 2017:

 

(Dollars in thousands)   March 31,
2019 		    December 31,
2018 		    March 31,
2018 		    December 31,
2017 		 
Cash and cash equivalents   $ 39,413     $ 12,447     $ 4,263     $ 7,307  
                                 
Restricted cash included in current/long term assets     586       561       692       692  
                                 
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 39,999     $ 13,008     $ 4,955     $ 7,998

Schedule of Antidilutive Securities

The following schedule details the number of shares issuable upon the exercise of stock options, warrants and conversion of preferred stock, which have been excluded from the diluted loss per share calculation as the inclusion would be anti-dilutive for the three months ended March 31, 2019 and 2018:

 

    As of March 31,  
    (in thousands)  
    2019     2018  
Stock options     16,572       11,614  
Preferred Stock and accrued dividend upon conversion     26,487       14,729  
Warrants     5,799       5,958  
Total     48,858       32,301